Patents by Inventor Miriam Kidron

Miriam Kidron has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND COMPOSITIONS FOR TREATING DIABETES
    Publication number: 20230210956
    Abstract: Described herein are methods and compositions for treating diabetes mellitus, concerning oral pharmaceutical compositions comprising insulin in combination with a GLP-1 analogue.
    Type: Application
    Filed: June 29, 2022
    Publication date: July 6, 2023
    Applicant: ORAMED LTD.
    Inventor: MIRIAM KIDRON
  • Methods and compositions for oral administration of proteins
    Patent number: 11660327
    Abstract: This invention provides compositions that include a protein and at least two protease inhibitors, method for treating diabetes mellitus, and methods for administering same, and methods for oral administration of a protein with an enzymatic activity, including orally administering same.
    Type: Grant
    Filed: December 23, 2020
    Date of Patent: May 30, 2023
    Assignee: Oramed Ltd.
    Inventor: Miriam Kidron
  • Methods and compositions for treating diabetes
    Patent number: 11395848
    Abstract: Described herein are methods and compositions for treating diabetes mellitus, concerning oral pharmaceutical compositions comprising insulin in combination with a GLP-1 analogue.
    Type: Grant
    Filed: March 23, 2020
    Date of Patent: July 26, 2022
    Assignee: ORAMED LTD.
    Inventor: Miriam Kidron
  • METHODS AND COMPOSITIONS FOR ORAL ADMINISTRATION OF PROTEINS
    Publication number: 20220160839
    Abstract: This invention provides compositions comprising a protein and an omega-3 fatty acid, method for treating diabetes mellitus, comprising administering same, and methods for oral administration of a protein with an enzymatic activity, comprising orally administering same.
    Type: Application
    Filed: November 29, 2021
    Publication date: May 26, 2022
    Inventor: Miriam Kidron
  • METHODS AND COMPOSITIONS FOR ORAL ADMINISTRATION
    Publication number: 20220151919
    Abstract: This invention provides compositions comprising a protein, an absorption enhancer, a protease inhibitor, method for treating diabetes mellitus, comprising administering same, and methods for oral administration of a protein with an enzymatic activity, comprising orally administering same.
    Type: Application
    Filed: January 31, 2022
    Publication date: May 19, 2022
    Applicant: Entera Bio Ltd.
    Inventors: Miriam KIDRON, Ehud ARBIT
  • Methods and compositions for oral administration
    Patent number: 11246827
    Abstract: This invention provides compositions comprising a protein, an absorption enhancer, a protease inhibitor, method for treating diabetes mellitus, comprising administering same, and methods for oral administration of a protein with an enzymatic activity, comprising orally administering same.
    Type: Grant
    Filed: August 21, 2019
    Date of Patent: February 15, 2022
    Assignee: Entera Bio Ltd.
    Inventors: Miriam Kidron, Ehud Arbit
  • Methods and Compositions for Treating NAFLD, Hepatic Steatosis, and Sequelae Thereof
    Publication number: 20220000986
    Abstract: Provided herein are oral pharmaceutical compositions containing a GLP-1 analogue and/or insulin for treating and reducing the incidence of nonalcoholic fatty liver disease (NAFLD), hepatic steatosis, and sequelae thereof, and methods of utilizing same.
    Type: Application
    Filed: March 19, 2021
    Publication date: January 6, 2022
    Applicant: ORAMED LTD.
    Inventors: Miriam KIDRON, Ehud ARBIT
  • Protease Inhibitor-Containing Compositions, Compositions Comprising Same, and Methods for Producing and Using Same
    Publication number: 20210369626
    Abstract: Provided herein are methods and compositions for oral administration of therapeutic proteins, improved protease inhibitor preparations, methods for producing same, and compositions comprising same.
    Type: Application
    Filed: February 1, 2021
    Publication date: December 2, 2021
    Applicant: Oramed Ltd.
    Inventors: Avraham HERSHKO, Miriam KIDRON
  • Methods and Compositions for Oral Administration of Exenatide
    Publication number: 20210322305
    Abstract: This invention provides compositions comprising a byetta, fish oil, and a protease inhibitor, method for treating diabetes mellitus, comprising administering same, and methods for oral or rectal administration of a byetta.
    Type: Application
    Filed: April 29, 2021
    Publication date: October 21, 2021
    Inventor: Miriam Kidron
  • Recombinant Protease Inhibitor-Containing Compositions, Methods for Producing Same and Uses Thereof
    Publication number: 20210244806
    Abstract: Provided herein are compositions for oral administration of therapeutic proteins and peptides, which compositions contain an isolated recombinantly expressed Bowman-Birk inhibitor (BBI) and which compositions provide for improved sustained activity of the therapeutic proteins and peptides. Methods of use of the compositions are provided, as well.
    Type: Application
    Filed: June 6, 2019
    Publication date: August 12, 2021
    Inventors: Miriam Kidron, Kajal Arora, Ramachandra Nagaraju, Nupur Mehrotra Arora, Prabuddha Kundu
  • Methods and Compositions for Oral Administration of Proteins
    Publication number: 20210113663
    Abstract: This invention provides compositions that include a protein and at least two protease inhibitors, method for treating diabetes mellitus, and methods for administering same, and methods for oral administration of a protein with an enzymatic activity, including orally administering same.
    Type: Application
    Filed: December 23, 2020
    Publication date: April 22, 2021
    Applicant: Oramed Ltd.
    Inventor: Miriam KIDRON
  • Methods and compositions for treating NAFLD, hepatic steatosis, and sequelae thereof
    Patent number: 10967051
    Abstract: Provided herein are oral pharmaceutical compositions containing a GLP-1 analogue and/or insulin for treating and reducing the incidence of nonalcoholic fatty liver disease (NAFLD), hepatic steatosis, and sequelae thereof, and methods of utilizing same.
    Type: Grant
    Filed: November 19, 2018
    Date of Patent: April 6, 2021
    Assignee: Oramed Ltd.
    Inventors: Miriam Kidron, Ehud Arbit
  • Methods and Compositions for Treating Diabetes
    Publication number: 20210077588
    Abstract: Described herein are methods and compositions for treating diabetes mellitus, concerning oral pharmaceutical compositions comprising insulin in combination with a GLP-1 analogue.
    Type: Application
    Filed: March 23, 2020
    Publication date: March 18, 2021
    Applicant: ORAMED LTD.
    Inventor: Miriam Kidron
  • Protease inhibitor-containing compositions, compositions comprising same, and methods for producing and using same
    Patent number: 10933022
    Abstract: Provided herein are methods and compositions for oral administration of therapeutic proteins, improved protease inhibitor preparations, methods for producing same, and compositions comprising same.
    Type: Grant
    Filed: May 9, 2019
    Date of Patent: March 2, 2021
    Assignee: Oramed Ltd.
    Inventors: Avraham Hershko, Miriam Kidron
  • Methods and compositions for oral administration of proteins
    Patent number: 10881714
    Abstract: This invention provides compositions that include a protein and at least two protease inhibitors, method for treating diabetes mellitus, and methods for administering same, and methods for oral administration of a protein with an enzymatic activity, including orally administering same.
    Type: Grant
    Filed: July 27, 2018
    Date of Patent: January 5, 2021
    Assignee: Oramed Ltd.
    Inventor: Miriam Kidron
  • METHODS AND COMPOSITIONS FOR ORAL ADMINISTRATION
    Publication number: 20190380953
    Abstract: This invention provides compositions comprising a protein, an absorption enhancer, a protease inhibitor, method for treating diabetes mellitus, comprising administering same, and methods for oral administration of a protein with an enzymatic activity, comprising orally administering same.
    Type: Application
    Filed: August 21, 2019
    Publication date: December 19, 2019
    Applicant: Entera Bio Ltd.
    Inventors: Miriam KIDRON, Ehud ARBIT
  • Methods and Compositions for Treating Diabetes
    Publication number: 20190374615
    Abstract: Described herein are methods and compositions for treating diabetes mellitus, concerning oral pharmaceutical compositions comprising insulin in combination with a GLP-1 analogue.
    Type: Application
    Filed: August 27, 2019
    Publication date: December 12, 2019
    Applicant: ORAMED LTD.
    Inventor: Miriam Kidron
  • Protease Inhibitor-Containing Compositions, Compositions Comprising Same, and Methods for Producing and Using Same
    Publication number: 20190321303
    Abstract: Provided herein are methods and compositions for oral administration of therapeutic proteins, improved protease inhibitor preparations, methods for producing same, and compositions comprising same.
    Type: Application
    Filed: May 9, 2019
    Publication date: October 24, 2019
    Applicant: Oramed Ltd.
    Inventors: Avraham Hershko, Miriam Kidron
  • Methods and Compositions for Rectal Administration of Exenatide
    Publication number: 20190314275
    Abstract: This invention provides compositions comprising a byetta, fish oil, and a protease inhibitor, method for treating diabetes mellitus, comprising administering same, and methods for oral or rectal administration of a byetta.
    Type: Application
    Filed: June 10, 2019
    Publication date: October 17, 2019
    Applicant: Oramed Ltd.
    Inventor: Miriam Kidron
  • Methods and compositions for oral administration
    Patent number: 10420721
    Abstract: This invention provides compositions comprising a protein, an absorption enhancer, a protease inhibitor, method for treating diabetes mellitus, comprising administering same, and methods for oral administration of a protein with an enzymatic activity, comprising orally administering same.
    Type: Grant
    Filed: June 6, 2018
    Date of Patent: September 24, 2019
    Assignee: Entera Bio Ltd.
    Inventors: Miriam Kidron, Ehud Arbit